Literature DB >> 6108175

Elevation of serum potassium during beta blockade: absence of relationship to the renin-aldosterone system.

Y M Traub, M Rabinov, J B Rosenfeld, S Treuherz.   

Abstract

Eighteen patients with essential hypertension were treated in a single-blind, crossover study with pindolol and with propranolol. The two drugs were compared because of known differences between them on renin secretion. We noted that plasma renin activity and plasma aldosterone concentration were suppressed by propranolol but not by pindolol. Blood pressure was reduced about equally by both drugs. Serum potassium levels rose in 17 patients on pindolol (p < 0.001) and in 14 patients on propranolol (p = 0.08). Our data suggest that serum potassium elevations induced by beta blockade do not depend on the renin-angiotensin-aldosterone system. Alternative possibilities are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108175     DOI: 10.1038/clpt.1980.233

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Authors:  Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

2.  Lack of influence of beta adrenergic blockade on serum potassium during an infusion of potassium.

Authors:  S R Smith; M J Kendall; C Ryder; S Laugher
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil.

Authors:  M Montiel; E Jiménez; J A Naváez; M Morell
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

Review 4.  Antihypertensive therapy and its effects on potassium homeostasis.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.